{
    "Fig 1": "Bioactive molecules with chiral THQs and DHQs.",
    "Fig 2": "1H NMR study of the interaction ofL1(0.02 M) with1f(0.06 M) and3a(0.06 M) in CDCl3.",
    "Fig 3": "DFT calculated energy potential surface for the proposed pathway (Ar = 3,5-di-CF3Ph; the phenyl groups on the phosphorus atoms are omitted for clarity; the relative Gibbs energies are labeled in kcal molâˆ’1).",
    "Scheme 1": "Asymmetric synthesis of chiral THQs and DHQs",
    "Scheme 2": "Asymmetric homogeneous hydrogenation of substrate3junder continuous flow conditions",
    "Scheme 3": "Deuterium labeling experiment and the proposed transformation path",
    "Scheme 4": "Outer-sphere mechanism for quinoxaline asymmetric hydrogenation",
    "Table 1": "Optimization of the reaction conditions for asymmetric hydrogenation of 2-methylquinoxaline hydrochloride1aa",
    "Table 2": "Ligand evaluation for asymmetric hydrogenation of 2-methylquinoxaline hydrochloride1aa",
    "Table 3": "Scope of quinoxaline derivativesa",
    "Table 4": "Scope of quinoxalinone derivativesa"
}